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Case presentation
A 30-year-old man was admitted to his local hospital because
of a history of several months of night sweats, a 20-pound weight
loss, anorexia, malaise, and increasing shortness of breath. After
the patient was given a short course of oral cephalexin, a chest
x-ray revealed a right pleural effusion and a large mediastinal
mass. A thoracentesis yielded 1500 cc of bloody fluid. Cytology
was not diagnostic.
He was transferred to New England Medical Center Hospital
(NEMCH) 2 days later for a mediastinal biopsy. On admission,
the patient was noted to have a severe superior vena cava syn-
drome. Mediastinal biopsy through a "mini-thoracotomy" fol-
lowed by emergency radiation therapy was planned, but a res-
piratory arrest during induction of anesthesia lead to an emergen-
cy tracheostomy, after which the patient received 400 rads to the
mass and i.v. dexamethasone. Percutaneous needle biopsy of the
mass the next morning was not diagnostic. The patient sub-
sequently received a total of 1000 rads to the mass during the
next few days. Although a second attempt at a mini-thoracotomy
proceeded without complication, a diagnosis could not be made
from the tissue obtained.
Representative blood values during the first admission were:
serum sodium, 147 mEq; potassium, 4.5 mEq; chloride, 98 mEq;
and bicarbonate, 30 mEq/liter; and BUN, 19 mg; serum creati-
nine, 0.7 mg; calcium, 8.6 mg; phosphorus, 4.9 mg; and uric acid,
4.9 mg/dl. Urinalysis revealed a specific gravity of 1.022, apH of
7, and I to 3 white blood cells/high-power field.
On discharge, allopurinol and dexamethasone were pre-
scribed, and the patient was scheduled to receive upper mantle
radiation therapy for a presumed lymphoma. Four days after dis-
charge, however, the patient was readmitted to NEMCH be-
cause of a 15-pound weight gain and lower leg edema. Blood
chemistry values on admission were serum sodium, 130 mEq;
potassium, 4.7 mEq; chloride, 102 mEq; and bicarbonate, 26
mEq/liter; and BUN 12 mg; serum creatinine, 0.7 mg; and uric
acid, 2.2 mg/dl. A low-salt diet and bed rest prompted a diuresis
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and his edema cleared. During that admission for approximately
2.5 weeks, 4000 rads were administered in a mantle pattern, and
he continued to receive allopurinol.
Ten weeks later the patient was hospitalized for the third time
with gross hematuria and bilateral flank discomfort. On examina-
tion he was afebrile with a blood pressure of 135/85 mm Hg. He
did not have palpable lymphadenopathy, and his abdomen was
soft with normal bowel sounds. A large, irregular mass was pal-
pable in the right flank as was a smaller irregular mass in the left
flank. The liver and speen could not be palpated.
Laboratory examination revealed serum sodium, 141 mEq; po-
tassium, 4.8 mEq; chloride, 102 mEq; and bicarbonate, 26 mEq/
liter; and BUN, 39 mg; serum creatinine, 3.6 mg; calcium, 9.4
mg; phosphorus, 5.6 mg; and uric acid, 7 mg/dl. The hemoglobin
was 11.4 g/dl, and the white blood count was 8600 cells/mm3.
Urinalysis revealed a specific gravity of 1.009, a pH of 6, 1+
protein, trace glucose, 5 to 10 white blood cells/high power field,
red cells per high-power field too numerous to count, and I to 2
fine granular casts/low-power field. No cellular casts were noted.
Urine output was 2075 cc per 24 hours. A renal echogram re-
vealed bilateral renal enlargement with no evidence of obstruc-
tion. A renal biopsy was performed.
Discussion
DR. CECIL H. COGGINS (Acting Chief, Renal
Unit, Massachusetts General Hospital, and Assist-
ant Professor of Medicine, Harvard Medical
School, Boston, Massachusetts): To summarize the
case, we have a 30-year-old man who, after several
months of fever and weight loss, was found to have
a bloody pleural effusion and a mediastinal mass
with superior vena cava syndrome. Two biopsies
were attempted but neither yielded a diagnosis. Fol-
lowing a brief course of radiotherapy for presumed
lymphoma, the patient was rehospitalized with leg
edema, which responded to conservative treatment.
He received more radiation. Two and one-half
months later, while still being treated with allopuri-
nol, he was again hospitalized, this time with flank
pain and hematuria. He had developed renal in-
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sufficiency with a serum creatinine of 3.6 mgldl.
Renal echography revealed large kidneys but no ob-
struction. A kidney biopsy apparently led to a diag-
nosis.
Lymphoma patients can develop renal failure in
several ways (Table 1). The lymphoma can directly
obstruct, infiltrate, or cause rupture of various por-
tions of the urinary tract. It can interfere indirectly
with renal function by causing hypercalcemia or
paraproteinemia, or it can lead through an immuno-
logic route to amyloidosis or glomerulonephritis.
Finally, the kidneys can be damaged as a result of
treatment directed to lymphoma. I will discuss
these mechanisms in detail while attempting to de-
termine the processes that occurred in this patient.
Probably the most common means by which lym-
phoma leads to renal failure is retroperitoneal ob-
struction of both ureters. In the very large series of
patients reported by Richmond et al, 4% of 696 pa-
tients with malignant lymphoma had evidence of bi-
lateral ureteral obstruction [1]. Obstruction also
was quite common in the series reported by Went-
zell [2] and that of Martinez-Maldonado [3]. The ob-
struction can result from direct compression of the
ureters by enlarging retroperitoneal lymph nodes,
by tumor invasion of the ureters themselves, or by
retroperitoneal fibrosis. Each of these processes
would be expected to produce gradual obstruction
of the ureters and lead to an appreciable degree of
dilation of the renal pelvis and calyces. The ul-
trasound study in our patient, however, did not
demonstrate distention of these structures. Since a
normal ultrasound examination reliably excludes
moderate to severe dilation [4], we can conclude
that his renal failure probably did not result from
ureteral obstruction by lymphoma,
Table 1. Renal failure in lymphoma
Direct effect
Obstruction of ureters
Compression, invasion or retroperitoneal fibrosis
Infiltration of kidneys
Obstruction of renal artery or vein
Rupture of renal pelvis or ureter
Indirect effect
Hypercalcemia
Bone invasion, PTH-like peptide, prostaglandins
Myeloma" kidney
Paraproteinemia, Bence-Jones proteinurla
Amyloid
Nephrosis or nephritis—immunologically mediated
Treatment-related
Radiation nephritis
Uric acid precipitate or stones
Xanthine precipitate or stones
Oxypurinol precipitate or stones
Lymphoma compressing or invading the renal
pedicle can obstruct the renal artery and cause hy-
pertension or it can occlude the renal vein. During
the patient's second hospitalization, when edema of
the legs was present, the possibility of compression
of the inferior vena cava must have been consid-
ered. Renal vein compression might have accom-
panied inferior vena cava obstruction at that time.
We are not told the results of urinalysis during that
admission, but if renal vein obstruction had been
present, one might have expected proteinuria to be
prominent. Was an inferior vena cavagram per-
formed?
DR. J. T. HARRINGTON: An inferior vena cay-
agram performed during that admission demon-
strated no clots in the vena cava or renal veins.
DR. C0GGINs: That information makes renal vein
thrombosis unlikely. His edema also might have
been related to nephrotic syndrome related to lym-
phoma. The results of the urinalysis and the serum
albumin concentration would be helpful in eval-
uating this possibility, as would the distribution of
edema; that is, was presacral edema present?
DR. HARRINGTON: During the second admission,
the edema was described as 3+ to 4+ to the level of
the groin; scrotal edema also was present; urinaly-
sis revealed a specific gravity of 1.022 with trace
protein and rare white blood cells; the serum albu-
min concentration was 3.1 g!dl on admission and
3.4 gIdl five days later.
DR. C0GGINs: Those data indicate that nephrotic
syndrome was not present. As I said earlier, rupture
of the renal pelvis or ureter with leakage of urine
into the retroperitoneal space or abdomen can
cause renal failure, and it has been reported with
Hodgkin's disease and other lymphomas [5, 6]. The
bilateral pain, normal echographic findings, and
continued good urine output all point away from
this possibility.
In addition to the direct physical effects that lym-
phoma can produce on the urinary tract, renal func-
tion can be impaired indirectly by hypercalcemia,
tumor products, or tumor antigens. Hypercalcemia,
which can result from direct bone invasion, release
of parathyroid hormone-like peptides by the tumor,
or the effects of prostaglandins, frequently occurs in
patients with lymphoma. Such hypercalcemia can
lead to nephrocalcinosis and renal failure [7]. At the
time this patient was hospitalized with an elevated
serum creatinine level, however, the serum calcium
was within the normal range. In so-called "myelo-
ma kidney," distal tubules and collecting ducts are
filled with casts containing monoclonal paraprotein
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or light chains that damage the adjacent tubular epi-
thelial cells and interstitium. This condition has
been found not only in patients with multiple myelo-
ma but also occasionally in those with malignant
lymphoma [8]. The degree of damage correlates
roughly with the quantity of light chains in the urine
(Bence-Jones proteinuria). Only I + proteinuria was
recorded during this patient's third admission; thus
this diagnosis seems unlikely. It should be noted
that if urinary protein is estimated by the use of the
"dipstick" technique, light chains can be over-
looked: the dipstick method for detecting protein
depends on the ability of certain proteins such as
albumin to effect a change in apparent activity co-
efficient and hence the pH of an indicator dye [9,
10]. This effect results in the indicator having one
color in the absence of protein and another color in
its presence. Light chains do not have this effect
[11]. I hope therefore that the dipstick quantitative
test was checked by a sulfosalicylic acid or heat-
acetic acid technique.
DR. HARRINGT0N: Electrophoresis of both serum
and urine revealed no paraprotein.
DR. C000INs: Those studies make myeloma kid-
ney unlikely. What about amyloidosis? Although
amyloid of the kidneys occurs more frequently as a
complication of multiple myeloma or as a "pri-
mary" event, it also occurs in some patients with
lymphoma—particularly in those with Hodgkin's
disease. It has been detected in from 3% to 10% of
such patients [12]. Amyloid infiltration would be
consistent with our patient's large-sized kidneys
and elevated serum creatinine, but it would be an
unlikely cause for the very rapid rate of kidney
growth and the modest proteinuria.
Glomerular injury has been associated with a
number of different kinds of malignant tumors [13].
In many cases the damage appears to result from
deposition of immune complexes containing tumor-
related antigens. Although membranous, mem-
branoproliferative, focal, and crescentic glomerulo-
nephritis have been reported in patients with lym-
phomas [14], a much more frequent finding is the
clinical picture of nephrotic syndrome with accom-
panying "minimal change" histopathology and no
evidence of immunoglobulin deposition. Whereas
an infectious agent, possibly a virus, could cause
both the lymphoma and the glomerular disease, or a
tumor-specific antigen might become deposited in
the glomerulus and lead to damage, it seems more
likely that the minimal change lesion results in some
way from an abnormality in T-cell function with a
defect in delayed hypersensitivity. It has been postu-
lated that an IgE-mediated mechanism might be in-
volved [15]. In this patient, however, we have no
clear evidence of nephrotic syndrome, and the mini-
mal proteinuria present during the final admission
would argue against primary glomerular injury.
Renal failure in a patient with lymphoma often re-
sults not from the disease but from the therapy ad-
ministered. Chronic radiation nephritis as a cause of
both glomerular and interstitial disease has been
recognized for many years and can occur when both
kidneys have received a dose in excess of 2300 rads
[16]. Signs and symptoms usually appear 6 to 12
months after the radiotherapy; proteinuria and hy-
pertension appear first and are followed by slowly
progressive renal insufficiency. In our patient
today, the rapid course and large kidneys do not
seem consistent with this diagnosis.
The last categories of treatment-associated renal
failure are related to pathways of purine metabolism
and excretion. The final metabolites of purines both
of endogenous nucleic acid and of dietary origin are
shown in Fig. 1. Normally a fraction of hypoxan-
thine is "salvaged" for reuse by means of the en-
zyme hypoxanthine-guanine phosphoribosyl trans-
ferase (HPRT). The remainder is transformed to
xanthine and thence to uric acid through the action
of the enzyme xanthine oxidase. Uric acid, the end
of the pathway, is the substance excreted in the
urine in humans. When patients with lymphoma are
treated with radiation or with cytotoxic agents, the
rapid breakdown of cells can result in excessive uric
acid production and excretion. When the urine vol-
ume is low, as in a dehydrated patient, the excreted
urate concentration becomes very high; when the
urine is acid, the bulk of urate is excreted in the
form of the relatively insoluble uric acid. Thus,
when the urine is acidic and concentrated, uric acid
can precipitate in the distal tubules and collecting
ducts and cause acute renal failure [17]. When the
release of uric acid from tissues occurs more slow-
ly, uric acid stones can form in the renal pelvis and
occasionally lead to ureteral obstruction.
The drug allopurinol, a structural analogue of
hypoxanthine, is converted to oxypurinol, an ana-
logue of xanthine, by xanthine oxidase. Both allo-
purinol and oxypurinol bind tightly to and are in-
hibitors of xanthine oxidase; they thus slow the
hypoxanthine-xanthine-uric acid transformations. In
normal people, treatment with allopurinol leads to
an increased fraction of hypoxanthine salvaged"
through the HPRT pathway and therefore to a re-
duction in total oxypurine excretion. Thus, allopuri-
nol given as routine therapy for patients undergoing
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Fig. 1. Allopurinol-oxypurine interrelations. HPRT is hypoxan-
thine-guanine phosphoribosyl transferase.
radiation or cytotoxic chemotherapy for lymphoma
virtually eliminates subsequent uric acid uropathy.
The serum uric acid level of 7 mg/dl in our patient
strongly suggests that uric acid precipitation in the
kidney is not the cause of his renal insufficiency.
It should be noted, however, that both xanthine
and oxypurinol are also relatively insoluble, espe-
cially in acidic urine. Monkeys given large doses of
allopurinol develop oxypurinol crystal deposits in
their kidneys [18]. Pigs who receive oral guanine
have increased purine excretion; when these ani-
mals are treated with allopurinol, renal deposits of
mixed xanthine and oxypurinol are produced [19].
Xanthine crystalluria and calculus formation is a
well-known complication in patients with heredi-
tary absence of xanthine oxidase, but recently some
allopurinol-treated patients without this hereditary
condition were found to form similar crystal depos-
its or stones [20]. During treatment of lymphoma,
the breakdown of large amounts of nucleic acid or
an increase in purine excretion comparable to that
occurring in patients with hereditary partial defi-
ciency of the enzyme HPRT [21] makes this deposi-
tion more likely. If crystal deposits were found in
our patient, I would have examined his red cells for
HPRT enzyme.
DR. HARRINGTON: The urine sediment did not re-
veal uric acid or other crystals. The patient's red
blood cells were not analyzed for HPRT.
DR. C0GGIN5: At this point, many of the mecha-
nisms that can produce renal failure in a patient
with a lymphoma can be regarded as quite unlikely
in the patient described here. The ultrasound find-
ings negate ureteral obstruction. The small amount
of proteinuria discredits renal vein thrombosis, am-
yloidosis, or glomerulonephritis. The patient had no
evidence of rupture of the renal pelvis or ureter.
Serum calcium was normal. Bence-Jones protein-
uria was not present, so "myeloma kidney" is un-
likely. The time interval between treatment and re-
nal insufficiency was too short for radiation nephri-
tis, and the normal uric acid levels make uric acid
uropathy unlikely. This leaves xanthine or oxypuri-
nol precipitation—admittedly a rare event—or renal
failure from tumor infiltration of the kidneys as the
remaining possible explanations for the renal failure
in this patient. I would now like to discuss the latter
situation in some detail.
Lymphomatous infiltration of the kidneys, a com-
mon finding at autopsy, occurs in 6% to 60% of pa-
tients [22], but it is extremely uncommon for the
infiltrate to replace functioning renal tissue so com-
pletely as to cause renal failure. Significant renal
failure occurred in only 0.5% of patients in the large
series previously mentioned [1]. Three other clini-
cal reports are of interest. In 6 patients with lym-
phoma complicated by acute renal insufficiency
who were encountered over a 6-year period in a
Paris dialysis unit, a variety of histologic findings
were noted [23]. In another report of a single pa-
tient, the initial presentation of a lymphocytic lym-
phoma was renal and the diagnosis was established
by renal biopsy [24]. Finally, in a third report, a re-
nal arteriogram led to the diagnosis of renal infil-
tration by lymphoma [25]. The tumor was hyper-
vascular with vessels stretched over and through
the infiltrating lesion. Since a good quality gray-
scale ultrasound examination can distinguish be-
tween the pattern of renal cortex and the more
echo-free medulla, and since lymphomatous tissue
in the kidney can change this pattern, further details
of the ultrasound findings might help us in reaching
a diagnosis in this patient. The finding of massive
lymphomatous involvement of both kidneys would
not assure us of the cause of renal failure, however,
since kidneys can be massively involved and often
still maintain relatively normal function. The diag-
nosis of renal failure secondary to lymphomatous
infiltration must be made by ruling out, as I have
tried to do today, other causes of renal failure.
We are left in the uncomfortable position of
choosing between two rare causes of renal in-
sufficiency. Infiltration of the kidneys by lymphoma
is present. Whether this infiltration is the cause of
the renal insufficiency is questionable, but no better
alternative is available, so I will posit that as the
likely diagnosis. The precipitation of xanthine, oxy-
purinol, or a combination of the two as a cause of
acute renal failure—particularly if the patient is
found to have a partial deficiency of HPRT—re-
mains a possibility, as does involvement of the renal
vasculature by lymphoma, although we have no
specific clues leading us to either of these diag-
noses.
The type of lymphoma also is undetermined. In a
patient such as ours who has no peripheral adeno-
inhibits
Xanthine Allopurinol
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pathy and no splenomegaly, one might ask whether
the basic diagnosis is lymphoma at all. In this di-
lemma I hope we are helped by the title of the case
presentation, 'Renal Failure in Lymphoma." Since
the presentation and progression of the patient as
described are consistent with lymphoma, I sup-
pose it is safe to stick with that diagnosis. Of the
various types of lymphoma, Hodgkin's disease can
produce all the changes seen here, although the ap-
parently sudden airway compromise is somewhat
unusual for this relatively slowly progressing lesion.
Lymphoblastic lymphoma is a common cause of
mediastinal masses and superior vena cava syn-
drome in children but not in adults. In addition, by
the time lymphoblastic lymphoma spreads to the in-
ferior vena cava and kidneys, it usually has pro-
gressed to a leukemic state. Diffuse histiocytic
(large cell) lymphoma is more common in adults,
can spread rapidly, and can cause the clinical fea-
tures present in our patient. I would guess that this
is the most likely lesion, and that the next most
likely is Hodgkin's disease. I am puzzled but de-
lighted that a kidney biopsy apparently led to the
diagnosis when two biopsies of the mediastinal
mass were nondiagnostic.
In summary, I would say that the patient has lym-
phoma with bilateral renal infiltration. The renal
failure could have resulted from either tumor infil-
tration directly or from precipitation of xanthine or
xanthine-oxypurinol crystals. If forced to pick one
diagnosis, I favor the first possibility.
Questions and answers
DR. SAMUEL THIER (Chairman, Department of
Internal Medicine, Yale University School of Medi-
cine, New Haven, Connecticut): In my own experi-
ence, gross hematuria has been uncommon even in
the unusual patient with renal insufficiency caused
by massive replacement of the kidney by lym-
phoma. Could you comment on this?
DR. C0GGINs: Yes, I do believe that gross hema-
tuna is uncommon, and I can only postulate that
small vessels ruptured within the renal interstitium.
Renal vein thrombosis might account for gross hem-
aturia in these patients. As pointed out earlier, how-
ever, an inferior vena cavagram performed during
this patient's second hospitalization revealed no
evidence of renal vein thrombosis.
DR. J. P. KASSIRER: You indicated that renal vein
thrombosis could be excluded because proteinuria
was minimal. I infer from this comment that you
consider heavy proteinuria a regular manifestation
of renal venous obstruction. I believe the evidence
points quite in the opposite direction, that is, that
renal diseases—particularly nephrotic syndrome—
are the factors that predispose toward renal vein
thrombosis. Extensive arguments in favor of this
hypothesis are mustered elsewhere [26], and I will
not repeat them, but many patients with renal
venous obstruction by tumor or extension of phle-
bothrombosis from the vena cava into the renal
veins do not have proteinuria [27-30]
DR. COGGINS: Yes, I am aware that renal vein
thrombosis tends to be the result of nephrotic syn-
drome rather than its cause. I thought, however,
that animal studies suggested that renal venous ob-
struction is usually followed by proteinuria.
DR. KASSIRER: I do not believe such studies are
convincing. In animals a nephrotic syndrome is pro-
duced by renal venous obstruction only when the
contralateral kidney is removed, but this model is
not closely relevant to the clinical phenomenon [31,
32]. Furthermore, many animals with experimental
nephrotic syndrome develop superimposed renal
vein thrombosis [33]; this also suggests that throm-
bosis is a secondary effect.
DR. J. J. COHEN: Dr. Coggins, if you had been
caring for this patient at this juncture, would you
have done any other studies before proceeding with
a renal biopsy?
DR. C0GGINs: I might have performed a CT scan
of the abdomen first. However, during the second
hospitalization the CT scan of the abdomen was not
particularly helpful. The results of an isotope scan
might have been informative.
DR. HARRINGTON: A technetium-99 glucohep-
tonate renal scan revealed good flow to both kid-
neys but cortical filling defects were noted bilat-
erally, and were more extensive on the right. The
four-day gallium-67 citrate scan showed marked
radionuclide uptake bilaterally, again greater on
the right than on the left.
DR. COGGINS: That information tells us that the
kidneys are likely affected by lymphoma but it still
does not tell us whether that involvement is respon-
sible for the loss of renal function. As I pointed out
earlier, a very good quality gray-scale ultrasound
examination can distinguish between renal cortex
and medulla, and characteristic abnormalities might
be found in patients with lymphomatous infiltration
within the kidney. I suspect, however, that neither
of these occurrences would have been convincingly
diagnostic, and I would have proceeded with a kid-
ney biopsy.
DR. ANGELO Ucci (Associate Pathologist,
NEMCH): The needle biopsy of the kidney shows
•
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Fig. 2A. Phototnicrograph showing diffuse infiltrate of renal parenchyma by lymphoma. Profiles of two renal tubules (T) remain (H &
E, x230).
Fig. 2B. Phototnicrograph of! .r epon section of the renal biopsy. Convoluted and lobulated tumor nuclei (arrows) are shown (toluidine
blue, X580).
Fig. 2C. Electron micrograph clearly showing the multiple deep nuclear clefts in the tumor cells (x2375).
diffuse dense infiltration of the renal parenchyma by
malignant lymphoma. Most of the normal renal ar-
chitecture is obliterated and only an occasional gb-
merulus or tubular profile is identifiable (Fig. 2A).
The tumor cells comprising the infiltrates are large
lymphoid cells with pleomorphic nuclei and ample
cytoplasm. Many of the tumor cell nuclei exhibit
multiple deep clefts resulting in a lobulated or con-
voluted nuclear shape (Fig. 2B). Electron micro-
graphs of the tumor cells demonstrate this con-
voluted nuclear morphology even more clearly (Fig.
2C). No crystalline deposits were noted in the kid-
ney, and the immunofluorescent studies for IgG,
IgA, 1gM, C3, C4, and fibrinogen were negative.
The cytologic and ultrastructural features of the
tumor, coupled with this patient's mediastinal
mass, indicate lymphoblastic lymphoma of con-
voluted T-cell type [34, 35]. Combined ultrastruc-
tural and immunologic studies of these T-cell lym-
phomas have revealed their extreme nuclear irregu-
larity or convolutions as a consistent and distinctive
feature [35]. Direct confirmation of T-cell markers
was precluded in this patient because the needle
biopsy provided insufficient tissue for cell-marker
studies. Histochemical stains for acid phosphatase,
which are positive in 50% ofT-cell lymphomas [36],
were negative in this patient.
The two mediastinal biopsies obtained after radi-
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Fig. 3. Gray scale ultrasonographic renal examination. Sagittal section of right kidney is shown in the upper panel (A and B); transverse
section of both kidneys, lower panel (C & D). A and C are the pretherapy findings, and B and Dare the posttherapy (5 months) findings.
ation therapy showed only necrosis, fibrosis, and
radiation effects. No identifiable tumor was noted.
Two bone marrow biopsies also were obtained, one
before and one after this patient's renal deteriora-
tion. Both showed no evidence of lymphoma.
Lymphoblastic lymphomas of convoluted T-cell
type represent a distinct clinicopathologic entity
with the following characteristic features: high in-
cidence in older children and adolescents; a high
male-to-female ratio; frequent presence of mediasti-
nat tumors at the time of diagnosis: and early bone
marrow involvement, which frequently is associat-
ed with a leukemic blood picture either early in the
course of the disease or at its terminal stages [34].
DR. DAVID BUSHINSKY (Renal Fellow,
NEMCH): Dr. Ucci, we recognize that more tissue
would have been required to obtain confirmation of
T-cell markers. It was the joint opinion of the On-
cology and Renal Services, however, that a specific
diagnosis could be made rapidly and that therapy
could be instituted using the information obtainable
from percutaneous kidney biopsy alone. The com-
bination of large kidneys as demonstrated by phys-
ical examination and ultrasound, the absence of ob-
struction and other reversible causes of renal fail-
ure, and the rapidity of the progressive renal
disease prompted the immediate performance of the
percutaneous biopsy.
DR. CoGcuINs: I would not be totally convinced
that T-cell lymphoma was the cause of the renal
functional impairment. We cannot deny that the pa-
tient's lymphoma accounts for the anatomic abnor-
malities observed. However, only reversibility of
the renal failure with appropriate therapy would
convince me that the lymphoma caused the renal
insufficiency.
DR. HARRINGTON: The patient was treated imme-
diately with radiation to both kidneys as well as
with chemotherapy consisting of Adriamycin, yin-
cristine, and prednisone. The serum creatinine level
peaked a few days later at 6.3 mgldl but fell over the
next several days to 1.4 mg/dI. Serum creatinine is
stable at the 1.2-1.5 mg/dl range approximately six
months later, and the patient is currently in appar-
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ent remission from lymphoma. We concluded that
the renal failure was due to the lymphomatous infil-
trate. Dr. Rudders, would you care to add any com-
ments regarding this patient?
DR. RICHARD A. RUDDERS (Hematology-Oncol-
ogy Division, NEMCH): I know this patient well
because I have been caring for him since the onset
of his illness. His was a most unusual and difficult
case, as we were forced to irradiate his mediastinal
tumor before a definitive tissue diagnosis could be
made. Although therapeutic radiation often allows
us to win the battle, that is, to relieve the vena cava
obstruction, it can cause us to lose the war because
histologic diagnosis at biopsy is often precluded af-
ter radiation, even if as little as 800 to 1200 rads
have been delivered. In this patient, the definitive
diagnosis was made when the patient relapsed. I
thought he had either lymphoblastic or histiocytic
lymphoma when I first examined him but could not
be sure. We elected to treat him initially with radia-
tion after exhausting all hope of arriving at a tissue
diagnosis. He first showed evidence of disease pro-
gression during radiation treatment and was then re-
hospitalized for a repeat biopsy. As has been noted,
he received radiation to his kidneys and was started
on a combination chemotherapy protocol similar in
type to current regimens used to treat acute child-
hood leukemia. With this newer approach, the grim
outlook of previous years has been reversed so that
most patients who have relatively early disease re-
spond to treatment, and many are long-term dis-
ease-free survivors [37].
DR. COHEN: We all were struck by the rapidity of
the renal failure and therefore proceeded rapidly
with treatment as described. As Dr. Coggins noted,
the proof that the lymphomatous infiltration was re-
sponsible for the renal insufficiency depended on
the patient showing improvement in renal function
following appropriate therapy. In addition to the im-
provement in serum creatinine, a follow-up so-
nographic examination five months later showed a
dramatic decrease in kidney size from approximate-
ly 15 toll cm (Fig. 3).
Reprint requests to Dr. Cecil H. Coggins, Renal Unit, Massa-
chusetts General Hospital, Boston, Massachusetts 02114
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